Variables | Group D (N = 50) | Group O (N = 50) | p |
---|---|---|---|
Anesthetic induction duration (min) | 26.9 ± 9.4 | 22.2 ± 9.2 | < 0.05a |
Bupivacaine consumption via epidural catheter (mg) | 14.5 ± 3 | 13.7 ± 2.7 | 0.54 |
Propofol consumption (mg) | 294.1 ± 34.1 | 324.5 ± 39.1 | 0.08 |
Intraoperative blood loss (ml) | < 30 | < 30 | 1.00 |
Intraoperative complication | 0 (0) | 0 (0) | 1.00 |
Conversion to thoracotomy | 0 (0) | 0 (0) | 1.00 |
Intraoperative alfentanil consumption (μg) |  | 742 ± 339.3 |  |
Postoperative pain control | |||
 Morphine consumption (mg) | 1.1 ± 1.8 | 2.4 ± 3.8 | < 0.05a |
 Parecoxib (Dynastat®) (mg) | 31.2 ± 16.7 | 27.2 ± 29.6 | 0.42 |
 Tramal (mg) | 2 ± 14.1 | 2 ± 14.1 | 1 |
 Ultracet® (tab) | 1.08 ± 2.53 | 0.86 ± 0 | 0.55 |
 Diclofenac (tab) | 0 ± 0.1 | 0.5 ± 1.6 | < 0.01b |
 Tramadol 37.5 mg + Acetaminophen 325 mg (Traceton®) (tab) | 0 | 0.4 ± 1 | < 0.01b |
Postoperative hospital stay (days) | 1.8 ± 0.8 | 2.9 ± 1.6 | < 0.001c |
Total hospital stay (days) | 4.5 ± 0.9 | 5.8 ± 2.7 | < 0.01b |